Mölnlycke safetac

Register to receive a free Europe Markets for Wound and Tissue Management report synopsis and brochure

In a multinational survey on the assessment of pain when removing dressings by Molnlycke, their Safetac® dressings were ranked as causing the least amount of pain to patients. When used in the place of some traditional adhesive-based dressings, dressings with Safetac technology demonstrably reduced traumatic injuries to wounds and peri-wound skin. They were also associated with significant reductions in the levels of wound-associated pain measured before, during and after dressing change. Advanced dressings with Safetac soft silicone adhesive technology significantly reduced pain during wear, at dressing removal, and after dressing change, when compared with advanced dressings with traditional adhesives.

It is possible that patients who suffer from acute and chronic wounds can interpret wound pain as a stressor. It is known from previous research that stress can delay wound healing; however, little is known about the influence of pain in this relationship. In the UK alone, wound care represents a chronic burden to the NHS, with over 200,000 people affected and total costs of £3.1 billion in 2006.

Pressure ulcers are common among elderly nursing home residents. To be effective in managing these wounds, a dressing should maintain a moist environment, facilitate healing, absorb exudate, remain in place for a number of days, and prevent trauma to the surrounding skin. In a recent clinical trial conducted by Molnlycke, most other dressings show evidence of stratum corneum attached to the adhesive, except those from Molnlycke, which appeared to be free of any attached stratum corneum. There were no peri-wound skin blisters reported following treatment with the absorbent foam dressing in any of the study patients.

About Mölnlycke
Mölnlycke Health Care is a world-leading provider of single-use surgical and wound care products for customers, healthcare professionals and patients. We develop and bring to market innovative wound care and surgical products along the entire continuum of care – from prevention to post-acute settings. Our solutions provide value for money, supported by clinical and health economic evidence.

References:

  1. Meaume S et al. A study to compare a new self adherent soft silicone dressing with a self adherent polymer dressing in stage II pressure ulcers. Ostomy Wound Management, 2003.
  2. Feili F et al. Retention capacity. Poster presentation at the EWMA conference, Lisbon, Portugal, 2008.
  3. Wiberg A.B et al. Preventing maceration with a soft silicone dressing: in-vitro evaluations. Poster presented at the 3rd Congress of the WUWHS, Toronto, Canada, 2008.
  4. Dykes PJ et al. Effect of adhesive dressings on the stratum corneum of the skin. Journal of Wound Care, 2001.
  5. Waring M et al. An evalution of the skin stripping of wound dressing adhesives. Journal of wound care, 2011.
  6. Johansson C. et al. An assessment of a self-adherent, soft silicone dressing in post operative wound care following hip and knee arthroplasty. Poster presentation at EWMA, Brussels, Belgium 2012.
  7. White R. A multinational survey of the assessment of pain when removing dressings. Wounds UK, 2008.
  8. Upton D. et al. The Impact of Atraumatic Vs Conventional Dressings on Pain and Stress in Patients with Chronic Wounds. Journal of Wound Care, 2012
  9. Upton D. et al. Pain and stress as contributors to delayed wound healing. Wound Practice and Research, 2010.
  10. Butcher M et al. Quantifying the financial impact of pain at dressing change. Psychological impact of pain in patients with wounds. Wounds UK, 2011

For Further Information
More on the wound dressing and other devices in the wound and tissue management market in Europe can be found in the 2015 edition report published by iData entitled Europe Markets for Wound and Tissue Management. This report includes segments for wound closure, static and dynamic compression therapy, non-adherent contact layers, hemostats, tissue sealants, anti-adhesion products, and negative pressure wound therapy, as well as advanced, moist, antimicrobial, interactive, and traditional wound dressings.

The global series on the market for wound and tissue management covers 22 countries, including the U.S., Japan, Australia, South Korea, Brazil, China, India and 15 countries in Europe. Full reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment.

Register online or email us at [email protected] for a Europe Markets for Wound and Tissue Management report brochure and synopsis.